In support of this hypothesis, our unpublished data reveal that plasma levels of ApoA1 are downregulated in both MDD patients and depressive-like mice and that plasma ApoA1 levels are negatively correlated with the severity of depressive symptoms and cognitive impairment in MDD patients. The gene discussed is APOA1; the disease is Cognitive impairment.